{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:39:04Z","timestamp":1648593544346},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf02751430","type":"journal-article","created":{"date-parts":[[2007,11,19]],"date-time":"2007-11-19T20:43:50Z","timestamp":1195505030000},"page":"525-538","source":"Crossref","is-referenced-by-count":1,"title":["An odyssey in search of a cure: The evolution of treatment of childhood acute lymphoblastic leukemia in the United Kingdom"],"prefix":"10.1007","volume":"60","author":[{"given":"Vaskar","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Eden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02751430_CR1","first-page":"17","volume":"73","author":"MA Mauer","year":"1970","unstructured":"Mauer MA, Simone JV. The current status of the treatment of childhood acute lymphoblastic leukaemia.Cancer Treat Rev 1970; 73: 17\u201341.","journal-title":"Cancer Treat Rev"},{"key":"BF02751430_CR2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0031-3955(16)36515-4","volume":"35","author":"DG Poplack","year":"1988","unstructured":"Poplack DG, Reman G. Acute lymphoblastic leukaemia in childhood.Pediatr Clin North Am 1988; 35: 903\u2013932.","journal-title":"Pediatr Clin North Am"},{"key":"BF02751430_CR3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/1097-0142(197808)42:2+<828::AID-CNCR2820420704>3.0.CO;2-W","volume":"42","author":"E Frei","year":"1978","unstructured":"Frei E, Sallan SE. Acute lymphoblastic leukaemia treatment.Cancer 1978; 42: 828\u2013838.","journal-title":"Cancer"},{"key":"BF02751430_CR4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1976.tb00950.x","volume":"32","author":"JV Simone","year":"1976","unstructured":"Simone JV. Factors that influence haematological remission duration in acute lymphoblastic leukaemia.Br J Haematol 1976; 32: 465\u2013472.","journal-title":"Br J Haematol"},{"key":"BF02751430_CR5","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/1097-0142(196512)18:12<1580::AID-CNCR2820181209>3.0.CO;2-T","volume":"18","author":"E Frei","year":"1965","unstructured":"Frei E. Progress in treatment for the leukaemias and lymphomas.Cancer 1965; 18: 1580\u20131584.","journal-title":"Cancer"},{"key":"BF02751430_CR6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/adc.42.224.441","volume":"42","author":"RM Hardisty","year":"1967","unstructured":"Hardisty RM, Norman PM. Meningeal leukaemia.Arch Dis Child 1967; 42: 441\u2013447.","journal-title":"Arch Dis Child"},{"key":"BF02751430_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/1097-0142(197008)26:2<404::AID-CNCR2820260222>3.0.CO;2-I","volume":"26","author":"AE Evans","year":"1970","unstructured":"Evans AE, Gilbert ES, Zandsitra R. Increasing incidence of central nervous system leukaemia in children.Cancer 1970; 26: 404\u2013409.","journal-title":"Cancer"},{"key":"BF02751430_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/adc.52.9.673","volume":"52","author":"MA Gribbon","year":"1977","unstructured":"Gribbon MA, Hardisty RM, Chessells JM. Long term control of central nervous system leukaemia.Arch Dis Child 1977; 52: 673\u2013678.","journal-title":"Arch Dis Child"},{"key":"BF02751430_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V37.3.272.272","volume":"37","author":"RJA Aur","year":"1971","unstructured":"Aur RJA, Simone JV, Husto HO et al. Central nervous system therapy and combination chemotherapy of childhood lymphoblastic leukaemia.Blood 1971; 37: 272\u2013281.","journal-title":"Blood"},{"key":"BF02751430_CR10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bmj.2.5863.381","volume":"2","author":"Medical Research Council","year":"1973","unstructured":"Medical Research Council. Treatment of acute lymphoblastic leukaemia: Effect of prophylactic therapy against central nervous system leukaemia.Br Med J 1973; 2: 381\u2013384.","journal-title":"Br Med J"},{"key":"BF02751430_CR11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/1097-0142(19820915)50:6<1031::AID-CNCR2820500602>3.0.CO;2-7","volume":"50","author":"DM Komp","year":"1982","unstructured":"Komp DM, Fernandez CH, Falletta JM et al. Central nervous system prophylaxis in acute lymphoblastic leukaemia.Cancer 1982; 50: 1031\u20131036.","journal-title":"Cancer"},{"key":"BF02751430_CR12","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/1097-0142(197811)42:5<2123::AID-CNCR2820420507>3.0.CO;2-5","volume":"42","author":"RJA Aur","year":"1978","unstructured":"Aur RJA, Simone JV, Verzosa MS et al. Childhood acute lymphoblastic leukaemia study VIII.Cancer 1978; 42: 2123\u20132134.","journal-title":"Cancer"},{"key":"BF02751430_CR13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/bmj.2.6140.787","volume":"2","author":"Medical Research Council","year":"1978","unstructured":"Medical Research Council. Effects of varying radiation schedule, cyclophosphamide treatment, and duration of treatment in acute lymphoblastic leukaemia.Br Med J 1978; 2: 787\u2013791.","journal-title":"Br Med J"},{"key":"BF02751430_CR14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mpo.2950100511","volume":"10","author":"Medical Research Council","year":"1982","unstructured":"Medical Research Council. The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III. The effect of added cytosine arabinsode and\/or asparaginase, and comparison of continuous and discontinuous mercaptopurine in regimens for standard risk ALL.Med Pediatr Oncol 1982; 10: 501\u2013510.","journal-title":"Med Pediatr Oncol"},{"key":"BF02751430_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mpo.2950100511","volume":"10","author":"Medical Research Council","year":"1982","unstructured":"Medical Research Council. The treatment of acute lymphoblastic leukaemia in childhood, UKALL VII.Med Pediatr Oncol 1982; 10: 501\u2013510.","journal-title":"Med Pediatr Oncol"},{"key":"BF02751430_CR16","first-page":"408","volume":"i","author":"Medical Research Council","year":"1986","unstructured":"Medical Research Council. UKALL trials 1972\u20131984. Improvement in treatment of children with acute lymphoblastic leukaemia.Lancet 1986; i: 408\u2013411.","journal-title":"Lancet"},{"key":"BF02751430_CR17","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/adc.60.11.1050","volume":"60","author":"Medical Research Council","year":"1985","unstructured":"Medical Research Council. Medical Research Council leukaemia trial UKALL VII.Arch Dis Child 1985; 60: 1050\u20131054.","journal-title":"Arch Dis Child"},{"key":"BF02751430_CR18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(81)92623-4","volume":"i","author":"M Sather","year":"1981","unstructured":"Sather M, Miller D, Nesbit M et al. Difference in prognosis for boys and girls with acute lymphoblastic leukaemia.Lancet 1981; i: 739\u2013745.","journal-title":"Lancet"},{"key":"BF02751430_CR19","first-page":"251","volume-title":"Leukaemia Research: Advances in Cell Biology and Treatment","author":"H Riehm","year":"1983","unstructured":"Riehm H, Hadner M, Henze G et al. Acute lymphoblastic leukaemia: treatment result in 3 BFM studies (1970\u201381). In: Murphy SB, Gilbert J, eds.Leukaemia Research: Advances in Cell Biology and Treatment. New York: Elsevier Biomedical, 1983: 251\u2013260."},{"key":"BF02751430_CR20","first-page":"241","volume-title":"Leukaemia Research: Advances in Cell biology and Treatment","author":"PF Coccia","year":"1983","unstructured":"Coccia PF. Development and preliminary findings of Children Cancer Study Group protocol (161, 162 and 163) for low, average and high risk acute lymphoblastic leukaemia in children In: Murphy SB, Gilbert J, eds.Leukaemia Research: Advances in Cell biology and Treatment. New York: Elsevier Biomedical, 1983: 241\u2013250."},{"key":"BF02751430_CR21","first-page":"448","volume":"30","author":"OB Eden","year":"1987","unstructured":"Eden OB, Lilleyman J, Shaw MP et al. Council Childhood leukaemia trial VIII compared with trial II\u2013VII: Lessons for future management.Haematol and Blood Transfus 1987; 30: 448\u2013455.","journal-title":"Haematol and Blood Transfus"},{"key":"BF02751430_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.1991.tb04415.x","volume":"78","author":"OB Eden","year":"1991","unstructured":"Eden OB, Lilleyman JS, Richards S et al. Results of MRC leukaemia trial UKALL VIII.Br J Haematol 1991; 78: 187\u2013196.","journal-title":"Br J Haematol"},{"key":"BF02751430_CR23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-3-642-74643-7_83","volume":"33","author":"SE Sallan","year":"1990","unstructured":"Sallan SE, Gelber RC, Kimball V et al. More is better! Update of Dana-Farber Cancer Institute\/Children's Hospital Childhood acute lymphoblastic leukaemia trials.Haematol Blood Transf 1990; 33: 459\u2013466.","journal-title":"Haematol Blood Transf"},{"key":"BF02751430_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/bjc.1991.263","volume":"64","author":"AD Pearson","year":"1991","unstructured":"Pearson AD, Amineddine HA, Yule M et al. The influence of serum methotrexate concentration and drug dosage on outcome in childhood acute lymphoblastic leukaemia.Br J Cancer 1991; 64: 169\u2013173.","journal-title":"Br J Cancer"},{"key":"BF02751430_CR25","first-page":"783","volume":"117","author":"R Krahl","year":"1990","unstructured":"Krahl R, Helbis W, Kubel M. Dose reduced induction therapy for acute leukaemia decreases both the complete remission and probability of leukaemia free survival.Folia Haematol Leipz 1990; 117: 783\u2013786.","journal-title":"Folia Haematol Leipz"},{"key":"BF02751430_CR26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(87)91840-X","volume":"ii","author":"NJ Shaw","year":"1987","unstructured":"Shaw NJ, Chapman ME, Eden OB. Treatment ofPneumocystic carinii infection in leukaemia.Lancet 1987; ii: 518\u2013519.","journal-title":"Lancet"},{"key":"BF02751430_CR27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08880018509141223","volume":"2","author":"P Darbyshire","year":"1985","unstructured":"Darbyshire P, Eden OB, Jamieson B et al. Pneumonitis in lymphoblastic leukaemia of childhood.Europ J Paediatr Haematol Oncol 1985; 2: 141\u2013147.","journal-title":"Europ J Paediatr Haematol Oncol"},{"key":"BF02751430_CR28","first-page":"5601","volume":"43","author":"SE Sallan","year":"1983","unstructured":"Sallan SE, Hitchcock-Bryan S, Gelber R et al. Influence of intensive asparaginase in the treatment of childhood non-T cell acute lymphoblastic leukaemia.Cancer Res 1983; 43: 5601\u20135607.","journal-title":"Cancer Res"},{"key":"BF02751430_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mpo.2950180612","volume":"18","author":"OB Eden","year":"1990","unstructured":"Eden OB, Shaw MP, Lilleyman JS, Richards S. Non-randomised study comparing toxicity ofEscherichia coli andErwinia asparaginase in children with leukaemia.Med Pediatr Oncol 1990; 18: 497\u2013502.","journal-title":"Med Pediatr Oncol"},{"key":"BF02751430_CR30","first-page":"12","volume":"24","author":"GK Rivera","year":"1987","unstructured":"Rivera GK, Mauer AM. Controversies in the management of childood acute lymphoblastic leukaemia: treatment intensification, CNS leukaemia and prognostic factors.Semin Haematol 1987; 24: 12\u201326.","journal-title":"Semin Haematol"},{"key":"BF02751430_CR31","first-page":"425","volume":"51","author":"SE Sallan","year":"1978","unstructured":"Sallan SE, Vamitta BM, Cassady JR et al. Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukaemia.Blood 1978; 51: 425\u2013433.","journal-title":"Blood"},{"key":"BF02751430_CR32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.1983.1.5.308","volume":"1","author":"ME Nesbit","year":"1983","unstructured":"Nesbit ME, Sather HN, Robinson LL et al. Randomised study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukaemia.J Clin Oncol 1983; 1: 308\u2013316.","journal-title":"J Clin Oncol"},{"key":"BF02751430_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4615-3898-1_14","volume-title":"Childhood Leukaemia: Present Problems and Future Prospects","author":"H Riehm","year":"1991","unstructured":"Riehm H. Results and significance of six randomised trials in four consecutive ALL-BFM studies. In: Kobaysashi N, Akera T, Mizutani S, eds,Childhood Leukaemia: Present Problems and Future Prospects. London: Kluwer Academic Publishers, 1991: 135\u2013148."},{"key":"BF02751430_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2008-1033805","volume":"194","author":"G Henze","year":"1982","unstructured":"Henze G, Langermann HJ, Fengler R et al. Therapiestudie BFM 79\/81 zur Behandlung der akuten lymphoblastichen Leukamie bie Kindern und Jungendichen: Intensivierte Reindutionstherapie fur Patientgruppen mit unterschiedlichem Rezidvrisiko.Klin Paediatr 1982; 194: 195\u2013203.","journal-title":"Klin Paediatr"},{"key":"BF02751430_CR35","first-page":"163","volume":"70","author":"L Norton","year":"1986","unstructured":"Norton L, Simon R. The Norton-Simon hypothesis revisited.Cancer Treat Rep 1986; 70: 163\u2013169.","journal-title":"Cancer Treat Rep"},{"key":"BF02751430_CR36","first-page":"122","volume":"12","author":"CM Niemeyer","year":"1985","unstructured":"Niemeyer CM, Hitchcock-Bryan S, Sallan SE. Comparative analysis of treatment programs for childhood acute lymphoblastic leukaemia.Semin Oncol 1985; 12: 122\u2013130.","journal-title":"Semin Oncol"},{"key":"BF02751430_CR37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","volume":"ii","author":"L Lennard","year":"1990","unstructured":"Lennard L, Lilleyman JS, Van-Loon J, Weinshilboum RM. Genetic variation in response to 6-mercptopurine for childhood acute lymphoblastic leukaemia.Lancet 1990; ii: 225\u2013229.","journal-title":"Lancet"},{"key":"BF02751430_CR38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/1097-0142(19860715)58:2+<473::AID-CNCR2820581311>3.0.CO;2-0","volume":"58","author":"DG Poplack","year":"1986","unstructured":"Poplack DG, Balis FM, Zimm S. The pharmacology of orally administered chemotherapy. A reappraisal.Cancer 1986; 58: 473\u2013480.","journal-title":"Cancer"},{"key":"BF02751430_CR39","first-page":"2342","volume":"43","author":"FM Balis","year":"1983","unstructured":"Balis FM, Savitch JL, Bleyer WA. Pharmacokinetics of oral methotrexate in children.Cancer Res 1983; 43: 2342\u20132345.","journal-title":"Cancer Res"},{"issue":"Suppl 2","key":"BF02751430_CR40","first-page":"S157","volume":"6","author":"JM Chessells","year":"1992","unstructured":"Chessells JM, Bailey CC, Richards S. MRC UKALL X. The UK protocol for childhood ALL: 1985\u20131990. The Medical Research Council Working Party on Childhood Leukaemia.Leukaemia 1992; 6 Suppl 2: S157-S161.","journal-title":"Leukaemia"},{"key":"BF02751430_CR41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1200\/JCO.1986.4.5.744","volume":"4","author":"PG Steinherz","year":"1986","unstructured":"Steinherz PG, Gaynon P, Miller DR et al. Improved disease-free survival of children with acute lymphoblastic leukaemia at high risk for early relapse with the New York regimen-a new intensive therapy protocol: a report from the Children's Cancer Study Group.J Clin Oncol 1986; 4: 744\u2013752.","journal-title":"J Clin Oncol"},{"key":"BF02751430_CR42","first-page":"437","volume":"33","author":"H Riehm","year":"1990","unstructured":"Riehm H, Gadner H, Henze G et al. Results and significance of six randomized trial in four consecutive ALL-BFM studies.Haematol Blood Transf 1990; 33: 437\u2013450.","journal-title":"Haematol Blood Transf"},{"key":"BF02751430_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/bjc.1992.32","volume":"65","author":"D Pinkel","year":"1992","unstructured":"Pinkel D. Lessons from 20 years of curative therapy of childhood acute leukaemia.Br J Cancer 1992; 65: 148\u2013153.","journal-title":"Br J Cancer"},{"key":"BF02751430_CR44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/bmj.296.6616.162","volume":"296","author":"K Wheeler","year":"1988","unstructured":"Wheeler K, Leiper AD, Jannoun L et al. Medical cost of curing childhood acute lymphoblastic leukaemia.Br Med J 1988; 296: 162\u2013166.","journal-title":"Br Med J"},{"key":"BF02751430_CR45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","volume":"324","author":"SE Lipshultz","year":"1991","unstructured":"Lipshultz SE, Colan SD, Gelber RD et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukaemia in childhood.N Engl J Med 1991; 324: 808\u2013815.","journal-title":"N Engl J Med"},{"key":"BF02751430_CR46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/bjc.1990.218","volume":"62","author":"OB Eden","year":"1990","unstructured":"Eden OB. CNS minimal disease therapy in childhood leukaemia: the place for irradiation.Br J Cancer 1990; 62: 6\u20137.","journal-title":"Br J Cancer"},{"key":"BF02751430_CR47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/adc.65.4.416","volume":"65","author":"JM Chessells","year":"1990","unstructured":"Chessells JM, Cox TCS, Kendall B et al. Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.Arch Dis Child 1990; 65: 416\u2013422.","journal-title":"Arch Dis Child"},{"key":"BF02751430_CR48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(81)91849-3","volume":"ii","author":"ME Nesbit","year":"1981","unstructured":"Nesbit ME, Robison LL, Littman PS et al. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: a comparison of 1800 rad and 2400 rad.Lancet 1981; ii: 461\u2013466.","journal-title":"Lancet"},{"key":"BF02751430_CR49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1097-0142(19910201)67:3<550::AID-CNCR2820670303>3.0.CO;2-#","volume":"67","author":"RA Krance","year":"1991","unstructured":"Krance RA, Newman EM, Ravindranath Y et al. A pilot study of intermediate dose methotrexate and ara-c \u201cspread out\u201d or \u201cup front\u201d in continuation therapy for childhood non-T, non-B acute lymphoblastic leukaemia.Cancer 1991; 67: 550\u2013556.","journal-title":"Cancer"},{"key":"BF02751430_CR50","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0360-3016(87)90308-7","volume":"13","author":"P Littman","year":"1987","unstructured":"Littman P Coccia P, Bleyer WA et al. Central nervous system prophylaxis in children with low risk acute lymphoblastic leukaemia.Int J Radiat Oncol Biol Phys 1987; 13: 1443\u20131449.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BF02751430_CR51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0022-3476(79)80137-7","volume":"94","author":"SM Shalet","year":"1979","unstructured":"Shalet SM, Price DA, Beardwill CG et al. Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukaemia.J Pediatr 1979; 94: 719\u2013722.","journal-title":"J Pediatr"},{"key":"BF02751430_CR52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08880018709141247","volume":"4","author":"L Sl\u00f8rdal","year":"1987","unstructured":"Sl\u00f8rdal L, Kolmannskog S, Moe PJ et al. High dose methotrexate (6\u20138 gm\/m2) in childhood malignancies: clinical tolerability and pharmacokinetics.Pediatr Haematol Oncol 1987; 4: 33\u201342.","journal-title":"Pediatr Haematol Oncol"},{"key":"BF02751430_CR53","first-page":"550","volume":"141","author":"PJ Starccski","year":"1987","unstructured":"Starccski PJ, Lee PA, Blatt J et al. Comparable effects of 1800- and 2400- rad cranial irradiation height and weight in children treated for acute lymphoblastic leukaemia.Am J Dis Child 1987; 141: 550\u2013552.","journal-title":"Am J Dis Child"},{"key":"BF02751430_CR54","first-page":"199","volume":"116","author":"U Radwanska","year":"198","unstructured":"Radwanska U, Michalewska D, Armata J et al. Acute lymphoblastic leukaemia therapy in Poland.Folia Haematol Leipzig 198; 116: 199\u2013210.","journal-title":"Folia Haematol Leipzig"},{"key":"BF02751430_CR55","first-page":"881","volume":"5","author":"BD Young","year":"1992","unstructured":"Young BD. Cytogenetic and molecular analysis of chromosome 11q23 abnormalities in leukaemia.Clin Haematol 1992; 5: 881\u2013896.","journal-title":"Clin Haematol"},{"issue":"Suppl 18","key":"BF02751430_CR56","first-page":"S54","volume":"66","author":"JM Chessells","year":"1992","unstructured":"Chessells JM. Leukaemia in the young child.Br J Cancer 1992; 66 (Suppl 18): S54-S57.","journal-title":"Br J Cancer"},{"key":"BF02751430_CR57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng1092-113","volume":"2","author":"M Djabali","year":"1992","unstructured":"Djabali M, Selleri L, Parry P et al. A trithorax like gene is interrupted by chromosome 11 q 23 translocations in acute leukaemias.Nature Genet 1992; 2: 113\u2013118.","journal-title":"Nature Genet"},{"key":"BF02751430_CR58","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0092-8674(92)90602-9","volume":"71","author":"DC Tkachuk","year":"1992","unstructured":"Tkachuk DC, Kohler S, Cleary M. Involvement of a homolog of drosophila trithorax by 11q23 chromosomal translocations in acute leukaemias.Cell 1992; 71: 691\u2013700.","journal-title":"Cell"},{"issue":"suppl 18","key":"BF02751430_CR59","first-page":"S76","volume":"66","author":"FL Johnson","year":"1992","unstructured":"Johnson FL, Rubin CM. Allogenic marrow transplantation in the treatment of infants with cancer.Br J Cancer 1992; 66 (suppl 18); S76-S79.","journal-title":"Br J Cancer"},{"key":"BF02751430_CR60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM198607313150501","volume":"315","author":"GK Rivera","year":"1986","unstructured":"Rivera GK, Buchanan G, Boyett JM et al. Intensive retreatment of childhood acute lymphoblastic leukaemia in first bone marrow relapse: a pediatric oncology group study.N Engl J Med 1986; 315: 273\u2013278.","journal-title":"N Engl J Med"},{"key":"BF02751430_CR61","first-page":"429","volume":"i","author":"A Butturini","year":"1986","unstructured":"Butturini A, Rivera GK, Bortin MM et al. Which treatment for childhood acute lymphoblastic leukaemia in second remission?Lancet 1986; i: 429\u2013432.","journal-title":"Lancet"},{"key":"BF02751430_CR62","doi-asserted-by":"crossref","unstructured":"Editorial. Treatment of childhood acute lymphoblastic leukaemia.Lancet 1988; i: 683\u2013684.","DOI":"10.1016\/S0140-6736(88)91480-8"},{"key":"BF02751430_CR63","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(86)91387-5","volume":"i","author":"J Chessells","year":"1986","unstructured":"Chessells J, Rogers DW, Leiper AD et al. Bone marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia.Lancet 1986; i: 1239\u20131241.","journal-title":"Lancet"},{"key":"BF02751430_CR64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/08880018809031258","volume":"5","author":"OB Eden","year":"1988","unstructured":"Eden OB, Stiller CA, Gerrard MP. Improved survival for childhood acute lymphoblastic leukaemia; possible effect of protocol compliance.Pediatr Hematol Oncol 1988; 5: 83\u201391.","journal-title":"Pediatr Hematol Oncol"},{"key":"BF02751430_CR65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/adc.64.5.657","volume":"64","author":"CA Stiller","year":"1989","unstructured":"Stiller CA, Draper GJ. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia.Arch Dis Child 1989; 64: 657\u2013661.","journal-title":"Arch Dis Child"},{"key":"BF02751430_CR66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/003693309303800305","volume":"38","author":"V Saha","year":"1993","unstructured":"Saha V, Eden T, Stiller CA et al. An audit of the activities of the pediatric oncology unit in Edinburgh, 1982\u201391.Scott Med J 1993; 38: 74\u201376.","journal-title":"Scott Med J"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02751430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02751430\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02751430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T10:54:22Z","timestamp":1588071262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02751430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF02751430"],"URL":"https:\/\/doi.org\/10.1007\/bf02751430","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}